Bolt Biotherapeutics Inc

Research Bolt Biotherapeutics Inc (BOLT) on Bullrun: market cap USD 7.50M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBOLT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.50M
• Financial periodFY2025
• RevenueUSD 7.70M
• Revenue growth0.1%
• Net income-USD 33.38M
• Free cash flow-USD 39.92M

Valuation Snapshot

latest market cap is USD 7.50M.

About Bolt Biotherapeutics Inc

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors;

Frequently asked questions

What is Bolt Biotherapeutics Inc's market cap?

Bolt Biotherapeutics Inc's market capitalization is USD 7.50M.

What does Bolt Biotherapeutics Inc do?

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer.